Draghia-Akli Ruxandra
Novavax, Inc. · EVP
Draghia-Akli Ruxandra is listed in public filings as officer: EVP, Research & Development. This Draghia-Akli Ruxandra insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Novavax, Inc. (NVAX). Investors use Draghia-Akli Ruxandra's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --34.9k shares | Grant / ExerciseMar 3, 2026 | Disclosure amount unavailable26.7k shares | -- | -- | |
| --53.3k shares | OtherMar 3, 2026 | Disclosure amount unavailable26.7k shares | -- | -- | |
| $224k23.6k shares | Grant / ExerciseMar 3, 2026 | $107.4K11.3k shares | $9.49 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.4M139.5k shares | Grant / ExerciseMar 2, 2026 | $1.4M139.5k shares | $10.11 | -- | |
| $1.3M139.5k shares | Grant / ExerciseMar 2, 2026 | $1.3M139.5k shares | $9.09 | -- | |
| --101k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable93k shares | -- | -- | |
| --14.3k shares | Grant / ExerciseNov 11, 2025 | Disclosure amount unavailable14.3k shares | -- | -- | |
| --28.5k shares | OtherNov 11, 2025 | Disclosure amount unavailable14.3k shares | -- | -- | |
| $61k8.2k shares | Grant / ExerciseNov 11, 2025 | $44.8K6k shares | $7.40 | -- | |
| $944k120k shares | Grant / ExerciseMar 3, 2025 | $944.4K120k shares | $7.87 | -- | |
| --80k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable80k shares | -- | -- | |
| $578k64.2k shares | Grant / ExerciseNov 11, 2024 | $578.0K64.2k shares | $9.01 | -- | |
| --42.8k shares | Grant / ExerciseNov 11, 2024 | Disclosure amount unavailable42.8k shares | -- | -- |